DBVT FY 2021 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-49.4% YoY

Gross Profit

-$4M-62.5% margin

Operating Income

-$99M-1727.6% margin

Net Income

-$98M-1713.5% margin

EPS (Diluted)

$-8.90

Cash Flow

Operating Cash Flow

-$108M

Free Cash Flow

-$109M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$146M

Total Liabilities

$47M

Stockholders' Equity

$99M

Cash & Equivalents

$77M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$11M	-49.4%
Gross Profit	-$4M	$11M	-131.6%
Operating Income	-$99M	-$159M	+37.9%
Net Income	-$98M	-$160M	+38.7%